This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Daegu Gyeongbuk Institute of Science, Institute for Basic Science, Pohang University of Science and Technology Foundation. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 99 
1 out of 1,113 Years Active: 2021
Title: The Innovative Contributions of Seung Jae Lee
Introduction
Seung Jae Lee is a notable inventor based in Pohang-si, South Korea. He has made significant strides in the field of biotechnology, particularly in anti-aging research. His work has the potential to impact various sectors, including pharmaceuticals and gerontology.
Latest Patents
Seung Jae Lee holds a patent for an innovative invention titled "Anti-aging transgenic Caenorhabditis elegans." This invention relates to a transgenic model in which a glutamine tRNA 5' terminus-derived fragment (Gln 5'-tsRNA) is overexpressed. The model is designed to inhibit aging, allowing researchers to investigate anti-aging mechanisms effectively. This advancement could significantly contribute to the development of new anti-aging drugs and the screening of age-inducing materials.
Career Highlights
Throughout his career, Seung Jae Lee has been associated with prominent institutions such as the Postech Academy-Industry Foundation and the Institute for Basic Science. His work in these organizations has facilitated groundbreaking research in the field of aging and biotechnology.
Collaborations
Seung Jae Lee has collaborated with esteemed colleagues, including Hong Gil Nam and Gyoo Yeol Jung. These partnerships have enhanced the scope and impact of his research endeavors.
Conclusion
Seung Jae Lee's contributions to anti-aging research through his innovative patent and collaborations with leading scientists underscore his importance in the field of biotechnology. His work continues to pave the way for advancements in understanding aging and developing potential therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile